Physical activity, fibrinogen plasma level and gene polymorphisms in postmenopausal women

被引:0
作者
Rauramaa, R
Vaisanen, S
Nissinen, A
Rankinen, T
Penttila, I
Saarikoski, S
Tuomilehto, J
Gagnon, J
Perusse, L
Bouchard, C
机构
[1] UNIV KUOPIO,DEPT PHYSIOL,FIN-70100 KUOPIO,FINLAND
[2] UNIV KUOPIO,DEPT COMMUNITY HLTH & GEN PRACTICE,FIN-70100 KUOPIO,FINLAND
[3] KUOPIO UNIV HOSP,DEPT CLIN CHEM,SF-70210 KUOPIO,FINLAND
[4] KUOPIO UNIV HOSP,DEPT OBSTET & GYNAECOL,SF-70210 KUOPIO,FINLAND
[5] NATL PUBL HLTH INST,HELSINKI,FINLAND
[6] UNIV LAVAL,PHYS ACTIV SCI LAB,QUEBEC CITY,PQ,CANADA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relations between habitual physical activity (PA), fibrinogen gene polymorphisms and plasma fibrinogen were investigated in 191 postmenopausal women. Subjects who reported PA at least 4 times/week had lower fibrinogen level (3.19 g/l, 95% CI 3.10: 3.27) than women reporting PA 2-3 times/week (3.43 g/l: 3.29: 3.58) or sedentary subjects (3.64 g/l, 3.33: 3.94). There were no differences in plasma fibrinogen across the alpha-fibrinogen (RsaI, TaqI) or beta-fibrinogen (MnII, BclI, HindIII) genotypes, the frequencies of which were in a Hardy-Weinberg equilibrium. An interaction between RsaI, which was in complete linkage disequilibrium with TaqI, and PA on plasma fibrinogen was observed, even after adjustments for BMI, smoking and medication (p = 0.024). Among women homozygous for the common RsaI allele, the physically most active had lower fibrinogen level (p <0.001) compared to the physically less active subjects. These results suggest that, in postmenopausal women, the relation between physical activity and plasma fibrinogen is modulated by genetic alpha-fibrinogen gene.
引用
收藏
页码:840 / 844
页数:5
相关论文
共 43 条
[1]  
BAUMANN RE, 1994, HUM GENET, V94, P165
[2]   beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction - The ECTIM study [J].
Behague, I ;
Poirier, O ;
Nicaud, V ;
Evans, A ;
Arveiler, D ;
Luc, G ;
Cambou, JP ;
Scarabin, PY ;
Bara, L ;
Green, F ;
Cambien, F .
CIRCULATION, 1996, 93 (03) :440-449
[3]   Fibrinogen is a predictor of mortality in coronary heart disease patients [J].
Benderly, M ;
Graff, E ;
ReicherReiss, H ;
Behar, S ;
Brunner, D ;
Goldbourt, U .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :351-356
[4]  
BERG K, 1989, CLIN GENET, V36, P229
[5]   IDENTIFICATION AND DISTRIBUTION OF FIBRINOGEN, FIBRIN, AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN ATHEROSCLEROSIS - USE OF MONOCLONAL-ANTIBODIES [J].
BINI, A ;
FENOGLIO, JJ ;
MESATEJADA, R ;
KUDRYK, B ;
KAPLAN, KL .
ARTERIOSCLEROSIS, 1989, 9 (01) :109-121
[6]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[7]   TURNOVER OF FIBRINOGEN, PLASMINOGEN, AND PROTHROMBIN DURING EXERCISE IN MAN [J].
COLLEN, D ;
SEMERARO, N ;
TRICOT, JP ;
VERMYLEN, J .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 42 (06) :865-873
[8]  
CONNOR JM, 1992, J MED GENET, V29, P480
[9]   Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris [J].
deMaat, MPM ;
deBart, ACW ;
Hennis, BC ;
Meijer, P ;
Havelaar, AC ;
Mulder, PGH ;
Kluft, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (09) :1156-1162
[10]  
ERNST E, 1993, EUR HEART J, V14, P82